Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,121 public trials 145 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Recruiting

A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)

NCT06122831

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Guangxi Zhuang Autonomous Region People's Hospital Nanning, Guangxi, China
  • Cangzhou People's Hosipital Cangzhou, Hebei, China
  • Affiliated Hospital of Chengde Medical College Chengde, Hebei, China
View all 22 locations
View Trial Details
Recruiting

Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET

NCT06552429

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Peking Union Hospital, Chinese Academy of Medical Sciences Beijing, China
  • Peking University People's Hospital Beijing, China
  • Union Hospital affiliated to Fujian Medical University Fujian, China
  • Nanfang Hospital, Southern Medical University Guangzhou, China
View Trial Details
Recruiting

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

NCT04260022

Conditions
B Cell Precursor Type Acute Leukemia, Blast Crisis, Bone Marrow Diseases, +35 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Augusta Cancer Center Augusta, Georgia, United States
View Trial Details
Recruiting

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

NCT03595917

Conditions
B-cell Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Burkitt Lymphoma, +27 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Recruiting

HPC Offered for PRESERVE Expansion

NCT07145411

Conditions
Anemia, Anemia, Aplastic, Anemia, Hemolytic, +31 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • Henry Ford Health Detroit, Michigan, United States
  • The Ohio State University Medical Center Columbus, Ohio, United States
  • Tristar Centennial Medical Center Nashville, Tennessee, United States
View Trial Details

Related conditions